Sorry, you need to enable JavaScript to visit this website.

XALKORI® (crizotinib) Principal Display Panel

PRINCIPAL DISPLAY PANEL - 250 mg Capsule Bottle Label

Pfizer

NDC 0069-8140-20

XALKORI®
(crizotinib) capsules,
for oral use

250 mg

60 Capsules
Rx only

PRINCIPAL DISPLAY PANEL - 250 mg Capsule Bottle Label

PRINCIPAL DISPLAY PANEL - 200 mg Capsule Bottle Label

Pfizer

NDC 0069-8141-20

XALKORI®
(crizotinib) capsules,
for oral use

200 mg

60 Capsules
Rx only

PRINCIPAL DISPLAY PANEL - 200 mg Capsule Bottle Label

What's New

No Current Announcements.

Search

Please enter your search term(s) for XALKORI®